Detalhe da pesquisa
1.
Pembrolizumab-induced agranulocytosis.
J Oncol Pharm Pract
; 30(4): 767-771, 2024 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-38291678
2.
Immune checkpoint inhibitors in advanced upper and lower tract urothelial carcinoma: a comparison of outcomes.
BJU Int
; 128(2): 196-205, 2021 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-33556233
3.
Impact of performance status on treatment outcomes: A real-world study of advanced urothelial cancer treated with immune checkpoint inhibitors.
Cancer
; 126(6): 1208-1216, 2020 03 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-31829450
4.
Histological Subtypes and Response to PD-1/PD-L1 Blockade in Advanced Urothelial Cancer: A Retrospective Study.
J Urol
; 204(1): 63-70, 2020 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-31971495
5.
Disseminated maculo-papular lesions in a patient in contact with cattle. / Lesiones máculo-papulosas diseminadas en paciente en contacto con ganado.
Enferm Infecc Microbiol Clin
; 35(9): 603-604, 2017 11.
Artigo
em Inglês, Espanhol
| MEDLINE | ID: mdl-27112975
6.
A New Prognostic Model in Patients with Advanced Urothelial Carcinoma Treated with First-line Immune Checkpoint Inhibitors.
Eur Urol Oncol
; 4(3): 464-472, 2021 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-33423945
7.
Facial nodulocystic eruption induced by sorafenib in a patient with hepatocellular carcinoma.
Indian J Dermatol Venereol Leprol
; 86(4): 409-411, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-32415051